Newron Pharmaceuticals S.p.A. Stock
Stocks
NWRN
IT0004147952
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.58 CHF | +1.40% |
|
-3.82% | -51.45% |
| 07-03 | Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment | MT |
| 05-05 | Edison Is Not Overly Concerned About a Trial Suspension |  |
| Market Cap | 261M 298M 240M 222M 418M 28.71B 427M 2.87B 1.13B 14.06B 1.12B 1.1B 48.4B | P/E 2026 * |
-9.1x | P/E 2027 * | 33.4x |
|---|---|---|---|---|---|
| Enterprise Value | 299M 342M 276M 254M 480M 32.97B 490M 3.3B 1.3B 16.15B 1.29B 1.26B 55.59B | EV / Sales 2026 * |
27.6x | EV / Sales 2027 * | 6.14x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Newron Pharmaceuticals S.p.A.
| 1 day | +1.40% | ||
| 1 week | -3.82% | ||
| Current month | -11.20% | ||
| 1 month | -3.66% | ||
| 3 months | -28.87% | ||
| 6 months | -53.12% | ||
| Current year | -51.45% |
| 1 week | 11.24 |  | 12.2 |
| 1 month | 11.24 | | 13.18 |
| Current year | 11.24 | | 31.85 |
| 1 year | 6.5 | | 31.85 |
| 3 years | 4.09 | | 31.85 |
| 5 years | 1.01 | | 31.85 |
| 10 years | 0.9 | | 31.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 62 | 2012-05-14 |
Roberto Galli
DFI | Director of Finance/CFO | - | 2011-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stefan Weber
BRD | Director/Board Member | 62 | 2012-05-14 |
Gillian Dines
BRD | Director/Board Member | - | 2023-03-31 |
Margarita Chavez
BRD | Director/Board Member | - | 2024-04-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/3/25 | Sell | 5,465 | 0.0274% | |||
| 12/3/25 | Fiscal year | Founder | 5,465 | 0.0274% | ||
| 11/27/25 | Sell | 14,567 | 0.0730% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.40% | -3.82% | +64.26% | +102.45% | 294M | |
| -1.29% | -2.54% | -0.35% | +4.30% | 49.7B | |
| +3.90% | -0.39% | +376.72% | +599.59% | 38.09B | |
| -1.70% | +4.46% | +7.46% | +57.67% | 35.29B | |
| -2.01% | -0.76% | +26.35% | -6.83% | 35.13B | |
| +0.06% | +1.56% | +4.41% | +27.42% | 27.22B | |
| +0.46% | -3.49% | - | - | 16.14B | |
| -0.04% | -0.09% | +68.48% | +117.39% | 15.36B | |
| +1.12% | +2.15% | +16.24% | +19.12% | 13.89B | |
| 0.00% | +1.36% | +15.74% | -30.62% | 13.02B | |
| Average | +0.16% | -1.02% | +64.37% | +98.94% | 24.41B | |
| Weighted average by Cap. | -0.15% | -0.65% | +75.19% | +119.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.84M 12.41M 10.01M 9.22M 17.38M 1.19B 17.77M 120M 47.04M 585M 46.6M 45.58M 2.01B | 44.83M 51.3M 41.37M 38.13M 71.87M 4.94B 73.47M 494M 194M 2.42B 193M 188M 8.33B |
| Net income | -31.17M -35.67M -28.77M -26.52M -49.98M -3.44B -51.09M -344M -135M -1.68B -134M -131M -5.79B | 5.02M 5.75M 4.64M 4.27M 8.05M 554M 8.23M 55.4M 21.79M 271M 21.59M 21.11M 933M |
| Net Debt | 38.68M 44.27M 35.7M 32.9M 62.02M 4.26B 63.39M 427M 168M 2.09B 166M 163M 7.19B | 14.72M 16.84M 13.58M 12.52M 23.59M 1.62B 24.12M 162M 63.84M 794M 63.24M 61.86M 2.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | CHF 11.58 | +1.40% | 28,715 |
| 26-07-16 | CHF 11.42 | -0.35% | 59,910 |
| 26-07-15 | CHF 11.46 | -1.04% | 78,260 |
| 26-07-14 | CHF 11.58 | -1.36% | 26,226 |
| 26-07-13 | CHF 11.74 | -0.51% | 34,169 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NWRN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
